Therapy News and Research

RSS

mRNA therapy revives p53 to combat ovarian tumors

Ovarian cancer is often very aggressive and responds poorly to the therapies currently available. A recent study by Goethe University Frankfurt and University Hospital Frankfurt offers hope that this could change in the medium term.

24 Jan 2024

European consortium awarded €6.5M to study psychedelic-assisted therapy

A European consortium of 19 partners has been awarded over €6.5M by the European Union to study psilocybin to treat psychological distress in people with progressive incurable illnesses requiring palliative care.

24 Jan 2024

Study shows how CBT rewires the anxious child's brain

Researchers at the National Institutes of Health have found overactivation in many brain regions, including the frontal and parietal lobes and the amygdala, in unmedicated children with anxiety disorders.

24 Jan 2024

AI Therapy companion 'replika' gains traction among lonely students

The young adult mental health outcomes of using a GPT3-enabled chatbot.

24 Jan 2024

RNA Therapies in Liver Disease: Insights from Ochre Bio's CEO

In this interview, we speak with Jack O'Meara, co-founder and CEO of Ochre Bio, a pioneering force in liver disease treatment. O'Meara shares insights into Ochre Bio's innovative RNA therapies, their approach to tackling liver disease, and the company's vision for the future.

24 Jan 2024

Preparing to hang up the car keys as we age

Lewis Morgenstern has made up his mind. When he turns 65 in four years, he's going to sign an advance directive for driving.

24 Jan 2024

In Los Angeles, occupational therapists tapped to help homeless stay housed

Carla Brown waits on an air mattress, eager for her occupational therapist to arrive at her apartment next to the Hollywood Freeway, mere blocks from where she once camped on the sidewalk.

24 Jan 2024

New mobile app proves effective in enhancing TB drug adherence

Mobile phone application called Gamified-Real-Time Video Observed Therapy or GRVOTS.

24 Jan 2024

Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins

In a joint effort to provide lower cost and more defined reagents and media to the cell and gene therapy market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, has signed a manufacturing, distribution, and collaboration agreement with Core Biogenesis, an innovator in the field of recombinant human proteins expressed in plants.

From Nucleus Biologics 24 Jan 2024

Bladder and gut fermentation syndromes: Uncommon disorders with significant implications

Study reviews bladder fermentation syndrome (BFS) and gut fermentation syndrome (GFS), highlighting their etiology, diagnosis, and treatment, and emphasizing the importance of recognizing these conditions to avoid misinterpretation in abstinence monitoring.

23 Jan 2024

New workflow identifies shared cancer targets, advancing immunotherapy

Researchers developed the Splicing Neo Antigen Finder (SNAF) workflow, integrating deep learning to identify shared immunogenic neoantigens in cancers, offering new targets for cancer immunotherapy, particularly in melanoma and ovarian cancer.

23 Jan 2024

Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers has found.

23 Jan 2024

Is a gluten-free diet always the healthier choice for women?

Study evaluates the impact of gluten-free diets on women's health, revealing benefits for specific gluten-related disorders but cautioning against unnecessary dietary restrictions.

23 Jan 2024

Cleveland Clinic and IBM researchers reveal strategy for identifying new immunotherapy targets through AI

Researchers from Cleveland Clinic and IBM have published a strategy for identifying new targets for immunotherapy through artificial intelligence (AI).

23 Jan 2024

AI model identifies sepsis patients before symptoms appear

Each year, at least 1.7 million adults in the United States develop sepsis, and approximately 350,000 will die from the serious blood infection that can trigger a life-threatening chain reaction throughout the entire body.

23 Jan 2024

Long-term prostate cancer treatment study informs decisions for diverse groups

A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.

23 Jan 2024

Study provides valuable insights into the evolutionary dynamics of hepatitis E virus

A combination therapy with multiple drugs is more effective than just one active compound. To begin with, at least.

23 Jan 2024

New study reveals effective strategies against drug resistance in hospital-acquired pneumonia treatment

A novel rabbit infection model to investigate meropenem's resistance development.

23 Jan 2024

Body mass index found to mediate causal associations between Helicobacter pylori infections and coronary artery disease risk

Coronary heart disease (CHD) and H. Pylori.

23 Jan 2024

Study identifies link between childhood family environment and cardiovascular health later in life

Throughout adulthood, adverse family experiences in childhood including abuse may increase the odds of poor cardiovascular health, while stable, nurturing caregiver relationships during childhood may increase the chances of optimal heart health throughout adulthood, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, a peer-reviewed American Heart Association journal.

23 Jan 2024

Therapy News and Research

mRNA therapy revives p53 to combat ovarian tumors

European consortium awarded €6.5M to study psychedelic-assisted therapy

Study shows how CBT rewires the anxious child's brain

AI Therapy companion 'replika' gains traction among lonely students

RNA Therapies in Liver Disease: Insights from Ochre Bio's CEO

Preparing to hang up the car keys as we age

In Los Angeles, occupational therapists tapped to help homeless stay housed

New mobile app proves effective in enhancing TB drug adherence

Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins

Bladder and gut fermentation syndromes: Uncommon disorders with significant implications

New workflow identifies shared cancer targets, advancing immunotherapy

Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Is a gluten-free diet always the healthier choice for women?

Cleveland Clinic and IBM researchers reveal strategy for identifying new immunotherapy targets through AI

AI model identifies sepsis patients before symptoms appear

Long-term prostate cancer treatment study informs decisions for diverse groups

Study provides valuable insights into the evolutionary dynamics of hepatitis E virus

New study reveals effective strategies against drug resistance in hospital-acquired pneumonia treatment

Body mass index found to mediate causal associations between Helicobacter pylori infections and coronary artery disease risk

Study identifies link between childhood family environment and cardiovascular health later in life

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News